| 94.92 0 (0%) | 04-24 15:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Cerner Corporation, an Oracle subsidiary since June 8, 2022, is a global provider of healthcare information technology solutions and tech-enabled services. Its flagship offering, the Cerner Millennium architecture, provides a person-centric computing framework. This framework integrates clinical, financial, and management information systems, empowering a wide array of healthcare professionals—including physicians, nurses, laboratory technicians, pharmacists, and administrative staff, as well as consumers—to efficiently access and manage an individual's electronic health record (EHR) directly at the point of care. Beyond Millennium, the company offers the cloud-based HealtheIntent platform for aggregating, transforming, and reconciling health data across the entire care continuum, and CareAware, an EHR-agnostic platform that facilitates seamless connectivity between medical devices and EHRs. Cerner’s comprehensive portfolio also includes various clinical and financial healthcare IT solutions, alongside specialized departmental and care coordination tools. In addition to its software, Cerner delivers a broad spectrum of tech-enabled services such as implementation, training, remote hosting, application management, revenue cycle optimization, support, maintenance, healthcare data analysis, real-world evidence solutions, clinical process optimization, transaction processing, and the management of employer health centers, all powered by data-driven insights. It also supplies complementary hardware and devices from third parties. Cerner serves an extensive client base, including integrated delivery networks, physician groups, managed care organizations, hospitals, medical centers, freestanding reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.
Tue, 07 Jun 2022
Oracle quietly closes $28B deal to buy electronic health records company Cerner - TechCrunch
Tue, 07 Jun 2022
Oracle Completes Acquisition of Cerner - Oracle
Wed, 18 May 2022
Cerner Collaboration to Increase Access to Cancer Clinical Trials - PR Newswire
Mon, 20 Dec 2021
Oracle to Buy Cerner for $28.3 Billion in Expansion Into Health - Bloomberg.com
Wed, 02 Jun 2021
Cerner Might Be an Acquisition Target Soon - InvestorPlace
Tue, 01 Dec 2020
Cerner Stock Price Forecast. Should You Buy CERN? - StockInvest.us
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|